Related Experiment Video
Updated: Jan 19, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Cardiovascular models for personalised medicine: Where now and where next?
D Rodney Hose1, Patricia V Lawford2, Wouter Huberts3
1Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield S10 2TN, UK; Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU), Trondheim, Norway; Insigneo Institute for in silico Medicine, University of Sheffield, Sheffield, UK.
Cardiovascular modeling is advancing with digital twin technology, integrating AI and machine learning. This aims to improve personal health and clinical practice through enhanced simulations and data assimilation for better patient outcomes.
Area of Science:
- Biomedical Engineering
- Computational Science
- Digital Health
Background:
- Digital twin technology is a key trend in engineering, integrating monitoring and simulation.
- Cardiovascular modeling is evolving towards a more systematic, multi-disciplinary approach.
Purpose of the Study:
- To overview the current state of cardiovascular modeling.
- To discuss challenges and processes for wider adoption in personal health and clinical practice.
Main Methods:
- Integrating physics, mathematics, control theory, AI, and machine learning.
- Enhancing collaboration between modeling and clinical communities.
- Developing model-based understanding for improved physiological measurements.
Main Results:
- Progress in physiological modeling, personalization, and uncertainty quantification.
- Exploration of models for clinical decision support.
- Identification of future steps and challenges in cardiovascular modeling.
Conclusions:
- Wider exploitation of cardiovascular modeling requires addressing challenges in integration and personalization.
- Digital twins and advanced simulation techniques are crucial for future advancements.
- Closer collaboration between engineers and clinicians is essential for clinical translation.
More Related Videos
10:37Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells
Published on: March 14, 2021
09:57Development and Evaluation of 3D-Printed Cardiovascular Phantoms for Interventional Planning and Training
Published on: January 18, 2021
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Physiological Models
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models